临床试验

Plasma Exchange Half-dose and Extracorporeal Detoxification for ACLF

NCT：NCT07593638 · NOT_YET_RECRUITING

NCT编号NCT07593638

状态NOT_YET_RECRUITING

SponsorUnidade Local de Saude do Nordeste (OTHER)

First posted2026-05-18

Last updated2026-05-18

简要摘要

Clinical trial The goal of this clinical trial is to learn if a liver support protocol works to treat Liver failure in adults. The main questions it aims to answer are: * Does hemoadsorption plus half-dose plasma exchange provide support to liver failure patients until recovery or transplant * What medical problems do participants have during the technique? Researchers will compare DPMAS plus half-dose plasma exchange with conventional treatment to evaluate a gain in recovery Participants will: * Be submitted to DPMAS plus half dose plasma exchange daily according to protocol. * Monitoring will be continuous in the ICU

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。